66 related articles for article (PubMed ID: 9127463)
1. Biochemical markers in osteoporosis.
Kanis JA
Scand J Clin Lab Invest Suppl; 1997; 227():6-11. PubMed ID: 9127463
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology, etiology, and diagnosis of osteoporosis.
Lane NE
Am J Obstet Gynecol; 2006 Feb; 194(2 Suppl):S3-11. PubMed ID: 16448873
[TBL] [Abstract][Full Text] [Related]
3. [Biochemical markers of bone turnover : clinical usefulness in osteoporosis].
Garnero P; Delmas PD
Ann Biol Clin (Paris); 1999; 57(2):137-48. PubMed ID: 10210740
[TBL] [Abstract][Full Text] [Related]
4. Role of biochemical markers of bone turnover as prognostic indicator of successful osteoporosis therapy.
Reginster JY; Collette J; Neuprez A; Zegels B; Deroisy R; Bruyere O
Bone; 2008 May; 42(5):832-6. PubMed ID: 18316258
[TBL] [Abstract][Full Text] [Related]
5. Relationship between BMD, dental panoramic radiographic findings and biochemical markers of bone turnover in diagnosis of osteoporosis.
Vlasiadis KZ; Damilakis J; Velegrakis GA; Skouteris CA; Fragouli I; Goumenou A; Matalliotakis J; Koumantakis EE
Maturitas; 2008 Mar; 59(3):226-33. PubMed ID: 18342460
[TBL] [Abstract][Full Text] [Related]
6. Contribution of bone mineral density and bone turnover markers to the estimation of risk of osteoporotic fracture in postmenopausal women.
Garnero P; Delmas PD
J Musculoskelet Neuronal Interact; 2004 Mar; 4(1):50-63. PubMed ID: 15615078
[TBL] [Abstract][Full Text] [Related]
7. Risk assessment for osteoporosis. II. Biochemical markers of bone turnover: bone resorption indices.
Woitge HW; Seibel MJ
Clin Lab Med; 2000 Sep; 20(3):503-25, vi. PubMed ID: 10986618
[TBL] [Abstract][Full Text] [Related]
8. Is bone mineral density predictive of fracture risk reduction?
Cefalu CA
Curr Med Res Opin; 2004 Mar; 20(3):341-9. PubMed ID: 15025843
[TBL] [Abstract][Full Text] [Related]
9. Monitoring osteoporosis therapy: bone mineral density, bone turnover markers, or both?
Bonnick SL; Shulman L
Am J Med; 2006 Apr; 119(4 Suppl 1):S25-31. PubMed ID: 16563938
[TBL] [Abstract][Full Text] [Related]
10. Role of biochemical markers in the management of osteoporosis.
Ebeling PR; Akesson K
Best Pract Res Clin Rheumatol; 2001 Jul; 15(3):385-400. PubMed ID: 11485336
[TBL] [Abstract][Full Text] [Related]
11. The value of biochemical markers of bone turnover in osteoporosis.
Eastell R; Blumsohn A
J Rheumatol; 1997 Jun; 24(6):1215-7. PubMed ID: 9195539
[TBL] [Abstract][Full Text] [Related]
12. Clinical usefulness of measurements of urinary deoxypyridinoline (DPD) in patients with postmenopausal osteoporosis receiving intermittent cyclical etidronate: advantage of free form of DPD over total DPD in predicting treatment efficacy.
Kitatani K; Nakatsuka K; Naka H; Miki T; Morii H; Nishizawa Y
J Bone Miner Metab; 2003; 21(4):217-24. PubMed ID: 12811626
[TBL] [Abstract][Full Text] [Related]
13. [The interest of biochemical markers of bone turnover for monitoring treatment of postmenopausal osteoporosis].
Kalaï E; Bahlous A; Makdouli A; Sahli H; Klouz A; Lakhal M; Sellami S; Abdelmoula J
Tunis Med; 2008 Feb; 86(2):122-7. PubMed ID: 18444527
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic equivalence of alendronate 70 mg once-weekly and alendronate 10 mg daily in the treatment of osteoporosis. Alendronate Once-Weekly Study Group.
Schnitzer T; Bone HG; Crepaldi G; Adami S; McClung M; Kiel D; Felsenberg D; Recker RR; Tonino RP; Roux C; Pinchera A; Foldes AJ; Greenspan SL; Levine MA; Emkey R; Santora AC; Kaur A; Thompson DE; Yates J; Orloff JJ
Aging (Milano); 2000 Feb; 12(1):1-12. PubMed ID: 10746426
[TBL] [Abstract][Full Text] [Related]
15. Biomarkers of bone health and osteoporosis risk.
Eastell R; Hannon RA
Proc Nutr Soc; 2008 May; 67(2):157-62. PubMed ID: 18412989
[TBL] [Abstract][Full Text] [Related]
16. Bone turnover markers in the management of postmenopausal osteoporosis.
Brown JP; Albert C; Nassar BA; Adachi JD; Cole D; Davison KS; Dooley KC; Don-Wauchope A; Douville P; Hanley DA; Jamal SA; Josse R; Kaiser S; Krahn J; Krause R; Kremer R; Lepage R; Letendre E; Morin S; Ooi DS; Papaioaonnou A; Ste-Marie LG
Clin Biochem; 2009 Jul; 42(10-11):929-42. PubMed ID: 19362543
[TBL] [Abstract][Full Text] [Related]
17. [Biochemical markers of bone remodeling: pre-analytical variations and guidelines for their use. SFBC (Société Française de Biologie Clinique) Work Group. Biochemical markers of bone remodeling].
Garnero P; Bianchi F; Carlier MC; Genty V; Jacob N; Kamel S; Kindermans C; Plouvier E; Pressac M; Souberbielle JC
Ann Biol Clin (Paris); 2000; 58(6):683-704. PubMed ID: 11098165
[TBL] [Abstract][Full Text] [Related]
18. Effects of chronic liver disease on bone mineral density and bone metabolism markers in postmenopausal women.
Uretmen S; Gol M; Cimrin D; Irmak E
Eur J Obstet Gynecol Reprod Biol; 2005 Nov; 123(1):67-71. PubMed ID: 16051419
[TBL] [Abstract][Full Text] [Related]
19. The use of biochemical markers of bone turnover in osteoporosis.
Allende-Vigo MZ
P R Health Sci J; 2007 Jun; 26(2):91-5. PubMed ID: 17722420
[TBL] [Abstract][Full Text] [Related]
20. ["Bone markers"--when can they be useful?].
Skjøstad JB
Tidsskr Nor Laegeforen; 1997 Sep; 117(22):3228-9. PubMed ID: 9411863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]